FDA Drug Recalls

Recalls / Class III

Class IIID-190-2013

Product

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules, 15 mg, Rx Only, C II, 100 capsules per bottle, MFG. By Actavis Elizabeth LLC. 200 Elmora Ave, Elizabeth, NJ, 07207, USA, NDC 0228-3063-11.

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate
Active ingredients
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate
Route
Oral
NDCs
0228-3059, 0228-3062, 0228-3063, 0228-3060, 0228-3064, 0228-3061
FDA application
ANDA077302
Affected lot / code info
Lot #: 50077231

Why it was recalled

Failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications. All other test specifications were met.

Recalling firm

Firm
Actavis Elizabeth LLC
Manufacturer
Actavis Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
200 Elmora Ave, N/A, Elizabeth, New Jersey 07207

Distribution

Quantity
9,264 Bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-02-13
FDA classified
2013-03-07
Posted by FDA
2013-03-13
Terminated
2014-03-06
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-190-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.